Cigna Group $CI Holdings Lifted by BI Asset Management Fondsmaeglerselskab A S

Key Points

• BI Asset Management Fondsmaeglerselskab A S nearly doubled its Cigna Group stake in Q1, increasing holdings by 99.2% to 35,118 shares valued at about $9.37 million.
• Cigna reported stronger-than-expected quarterly results, posting $7.79 EPS versus the $7.60 consensus and revenue of $68.52 billion, up 4.6% year over year.
• The company also paid a quarterly dividend of $1.56 per share and maintained a modest payout ratio of 26.45%, while analysts currently rate the stock a “Moderate Buy” with an average target price of $338.30.

BI Asset Management Fondsmaeglerselskab A S increased its holdings in Cigna Group (NYSE:CI - Free Report) by 99.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,118 shares of the health services provider's stock after buying an additional 17,488 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in Cigna Group were worth $9,368,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Banco Bilbao Vizcaya Argentaria S.A. increased its position in shares of Cigna Group by 13.5% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider's stock valued at $9,839,000 after purchasing an additional 4,066 shares during the period. Distillate Capital Partners LLC lifted its holdings in shares of Cigna Group by 19.1% in the third quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider's stock valued at $31,338,000 after buying an additional 17,442 shares during the period. Cooperman Leon G lifted its holdings in shares of Cigna Group by 53.3% in the third quarter. Cooperman Leon G now owns 325,000 shares of the health services provider's stock valued at $93,681,000 after buying an additional 113,000 shares during the period. apricus wealth LLC boosted its stake in Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider's stock valued at $2,616,000 after buying an additional 8,340 shares in the last quarter. Finally, Schroder Investment Management Group boosted its stake in Cigna Group by 53.0% during the third quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider's stock valued at $54,972,000 after buying an additional 66,090 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

Cigna Group Trading Up 0.1%

Shares of NYSE CI opened at $279.63 on Monday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The company has a market cap of $73.97 billion, a price-to-earnings ratio of 11.85, a P/E/G ratio of 1.08 and a beta of 0.28. The business has a fifty day simple moving average of $283.79 and a 200-day simple moving average of $278.36.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same period in the prior year, the firm earned $6.74 earnings per share. The business's quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group's dividend payout ratio is 26.45%.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the firm's stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares of the company's stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CI. Barclays cut shares of Cigna Group from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $310.00 to $304.00 in a research report on Tuesday, May 26th. Piper Sandler lowered their price objective on shares of Cigna Group from $370.00 to $346.00 and set an "overweight" rating on the stock in a research note on Wednesday, June 3rd. Sanford C. Bernstein boosted their target price on shares of Cigna Group from $358.00 to $371.00 and gave the stock an "outperform" rating in a report on Tuesday, May 5th. Royal Bank Of Canada boosted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a report on Friday, May 1st. Finally, Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Cigna Group presently has a consensus rating of "Moderate Buy" and an average target price of $338.30.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.